Mixed effects modeling of proliferation rates in cell-based models: consequence for pharmacogenomics and cancer.
Mixed effects modeling of proliferation rates in cell-based models: consequence for pharmacogenomics and cancer. PLoS Genet. 2012 Feb; 8(2):e1002525.